Thomas-Orogan Oluwabukola, Barratt Shaney L, Zafran Muhammad, Kwok Apollo, Simons Anneliese, Judge Eoin P, Wells Matthew, Daly Richard, Sharp Charles, Jeyabalan Abiramy, Plummeridge Martin, Chandratreya Ladli, Spencer Lisa G, Medford Andrew R L, Adamali Huzaifa I
Bristol Interstitial Lung Disease Service, North Bristol NHS Trust, Bristol BS10 5NB, UK.
Liverpool Interstitial Lung Disease Service, Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8XP, UK.
Diagnostics (Basel). 2024 Jan 23;14(3):237. doi: 10.3390/diagnostics14030237.
Sarcoidosis is a multi-system granulomatous disease most commonly involving the lungs. It may be incidentally diagnosed during imaging studies for other conditions or non-specific symptoms. The appropriate follow-up of incidentally diagnosed asymptomatic stage 1 disease has not been well defined.
To define the clinical course of incidentally diagnosed asymptomatic stage 1 sarcoidosis and propose an algorithm for the follow-up of these patients.
A retrospective case note analysis was performed of all EBUS-TBNA (endobronchial ultrasound-guided transbronchial needle aspiration)-confirmed cases of stage 1 sarcoidosis presenting incidentally to Bristol and Liverpool Interstitial Lung Disease services. Clinical history, serology results, imaging scans, and lung function parameters were examined at baseline, 12, and 24 months. A cost analysis was performed comparing the cost of the current 2-year follow-up guidance to a 1 year follow-up period.
Sixty-seven patients were identified as the final cohort. There was no significant change in the pulmonary function tests over the two-year follow-up period. Radiological disease stability was observed in the majority of patients (58%, = 29), and disease regression was evidenced in 40% ( = 20) at 1 year. Where imaging was performed at 2 years, the majority (69.8%, = 37) had radiological evidence of disease regression, and 30.2% ( = 16) showed radiological evidence of stability. All patients remained asymptomatic and did not require therapeutic intervention over the study period.
Our results show that asymptomatic patients with incidental findings of thoracic lymph nodal non-caseating granulomas do not progress over a 2-year period. Our results suggest that the prolonged secondary-care follow-up of such patients may not be necessary. We propose that these patients are followed up for 1 year with a further year of patient-initiated follow-up (PIFU) prior to discharge.
结节病是一种多系统肉芽肿性疾病,最常累及肺部。它可能在因其他病症进行影像学检查或出现非特异性症状时被偶然诊断出来。对于偶然诊断出的无症状1期疾病,合适的随访方案尚未明确界定。
明确偶然诊断出的无症状1期结节病的临床病程,并提出针对这些患者的随访算法。
对所有经支气管内超声引导下经支气管针吸活检(EBUS-TBNA)确诊为1期结节病且偶然就诊于布里斯托尔和利物浦间质性肺病服务机构的病例进行回顾性病例记录分析。在基线、12个月和24个月时检查临床病史、血清学结果、影像学扫描和肺功能参数。进行成本分析,比较当前2年随访指导的成本与1年随访期的成本。
确定67例患者为最终队列。在两年的随访期内,肺功能测试无显著变化。大多数患者(58%,n = 29)观察到放射学疾病稳定,1年时40%(n = 20)有疾病消退证据。在2年时进行影像学检查的患者中,大多数(69.8%,n = 37)有疾病消退的放射学证据,30.2%(n = 16)显示放射学稳定证据。所有患者在研究期间均无症状,无需治疗干预。
我们的结果表明,偶然发现胸部淋巴结非干酪样肉芽肿的无症状患者在2年内病情无进展。我们的结果表明,对此类患者进行长期二级护理随访可能没有必要。我们建议对这些患者进行1年随访,出院前再进行1年患者自主随访(PIFU)。